Credit Suisse’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-9,632
| Closed | -$1.27M | – | 3689 |
|
|
2020
Q4 | $1.27M | Buy |
9,632
+3,775
| +64% | +$497K | ﹤0.01% | 2417 |
|
|
2020
Q3 | $295K | Buy |
5,857
+73
| +1% | +$3.68K | ﹤0.01% | 2924 |
|
|
2020
Q2 | $276K | Buy |
5,784
+176
| +3% | +$8.4K | ﹤0.01% | 2983 |
|
|
2020
Q1 | $275K | Sell |
5,608
-21,184
| -79% | -$1.04M | ﹤0.01% | 2878 |
|
|
2019
Q4 | $1.54M | Buy |
26,792
+8,683
| +48% | +$498K | ﹤0.01% | 2240 |
|
|
2019
Q3 | $651K | Buy |
+18,109
| New | +$651K | ﹤0.01% | 2653 |
|